EXT2 and cancer: Data from the The Cancer Genome Atlas (TCGA) and Genotype Tissue Expression (GTEx) database, consulted by OncoDB, showed that CDK4 and EXT2 mRNA expression increased with malignancy augmentation, rising from normal brain tissue, passing through LGG, ending in GBM (Figure 4).